Yuce Biotechnology

Yuce Biotechnology

Starting with precision， striving for health

Founded 2019 China

China 3 employees Series B Total: $100.00M Health Care

Yuce Biotechnology is a high-tech company founded in 2019, with a focus on industrializing single molecule immunoassay. Their core technology, SMID, holds independent intellectual property rights and is dedicated to precise detection for human health and technical innovation for an infinite future. The company's slogan, "Starting with precision, striving for health," underscores their commitment to revolutionizing health technology. AstraBio’s SMID technology is designed to empower researchers in bringing new discoveries in disease and treatment to the forefront. Their instruments are ultra-sensitive, high-throughput, fully automatic, and cost-effective, offering a wide-ranging menu of assay kits. Notably, their cutting-edge instruments have the ability to detect neurological biomarkers at ultra-low levels (fg/ml), holding the potential to transform the way brain injuries and diseases are diagnosed. Furthermore, they enable a better understanding of the long-term effects and disease pathology with a less invasive method. The company recently secured a Series B investment on 27 May 2024 from LH Ventures, indicating a strong interest from the investor community in AstraBio's innovative approach to revolutionizing health technology. With their headquarters in China, AstraBio is poised to continue making strides in the biotechnology sector with their groundbreaking SMID technology.

Funding Stage	Amount	Investors	Lead Investors	Date
Series B	Undisclosed	1	LH Ventures	27 May 2024
Series B	Undisclosed	3	BioTrack Capital, Chuang Capital +1	22 Mar 2024
Series A	CNY100.00M	3	Puhua Capital, Boyuan Capital +1	29 Jun 2022

Funding Stage

Amount

Investors

Lead Investors

Date

Series B

Undisclosed

LH Ventures

27 May 2024

Series B

Undisclosed

BioTrack Capital, Chuang Capital +1

22 Mar 2024

Series A

CNY100.00M

Puhua Capital, Boyuan Capital +1

29 Jun 2022

FAQ About Yuce Biotechnology

Starting with precision， striving for health

Yuce Biotechnology was founded in 2019.

Yuce Biotechnology is headquartered in China.

Yuce Biotechnology operates in Health Care. Its work centres on single-molecule immunoassay, medical diagnostics, neurological biomarkers and R&D.

Yuce Biotechnology has approximately 3 employees.

Yuce Biotechnology has completed 3 funding rounds, raising a total of $100.00M. The latest funding stage is Series B.

Top alternatives and competitors to Yuce Biotechnology include Quanterix, Qritive, ANCON Medical, Cleveland Diagnostics, JaxBio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Yuce Biotechnology and Quanterix are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Yuce Biotechnology

Funding Rounds & Investors (3)

Yuce Biotechnology Alternatives & Competitors

FAQ About Yuce Biotechnology